Sumitomo Pharma Co Ltd (STU:DPM)
€ 3.66 -0.1 (-2.66%) Market Cap: 1.50 Bil Enterprise Value: 3.90 Bil PE Ratio: 0 PB Ratio: 1.53 GF Score: 59/100

Full Year 2023 Sumitomo Pharma Co Ltd Earnings Presentation Transcript

May 15, 2023 / 04:00AM GMT
Release Date Price: €5.3 (+0.95%)

May 15, 2023 / 04:00AM GMT
Presentation
May 15, 2023 / 04:00AM GMT

=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Pharma Co., Ltd. - CEO, President & Representative Director
* Naoki Noguchi
Sumitomo Pharma America Holdings, Inc. - Director of Business Development
* Toru Kimura
Sumitomo Pharma Co., Ltd. - EVP Global Corporate Stgy,Fin&Acc,Regenerative & Cellular Medicine Off. and Representive Director
* Yoshiharu Ikeda
Sumitomo Pharma Co., Ltd. - Senior Executive Officer of Drug Research Division, Head of Japan Business Unit and Director

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kasumi Haruta
Crédit Suisse AG, Research Division - Research Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Yuto Yoshida

================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot